Clinical & translational oncology

• 

  Año 2019, Vol. 21, Número 2 (February)

  • Review Article

    • New horizons in breast cancer: the promise of immunotherapy

      Luis de la Cruz-Merino, N. Palazón Carrión, F. Henao Carrasco, E. Nogales Fernández, María del Carmen Álamo de la Gala, A.M. Vallejo Benítez, Massimo Chiesa, Víctor Sánchez-Margalet, GEICAM, Madrid, GÉTICA

      • Resumen

      págs. 117-125

      

    • The microRNA signatures: aberrantly expressed miRNAs in prostate cancer

      Neeti Sharma, Meghna M. Baruah

      • Resumen

      págs. 126-144

      

    • Molecular biomarkers for prognosis of gastrointestinal stromal tumor

      X. Liu, Kent-Man Chu

      • Resumen

      págs. 145-151

      

    • Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy

      S. Jiang, C. Hu, P. Liu, Min Lu

      • Resumen

      págs. 152-159

      

    • Do locally advanced and metastatic human epithelial cancers evolve in ‘placental/decidual-like microenvironments’?

      Miguel Hernandez Bronchud

      • Resumen

      págs. 160-166

      

  • Research Article

    • CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study

      X. Zhang, J. Zhou, D.-D. Zhu, J. Huang, J.-H. Sun, T.-F. Li, C.-S. Shi, Z.-C. Sun, Q.-M. Hou, Z.-Y. Peng, W.-Q. Yu, J.-S. Ji, W.-J. Gu, G.-H. Zhou, X.-X. Xie, X.-H. Guo, G.-H. Cao, Z.-H. Yu, H.-H. Xu, J. Fang, S.-H. Ying, W.-H. Hu, W.-B. Ji, J. Han, X. Wu, J.-P. Zheng, J. Luo, Y.-T. Chen, T.-Y. Hu, L. Li, H.-J. Hu, H.-J. Du, Guoliang Shao

      • Resumen

      págs. 167-177

      

    • Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation

      F. Bartel, M. van Herk, H. Vrenken, F. Vandaele, Stefan Sunaert, K. de Jaeger, N. J. Dollekamp, C. Carbaat, E. Lamers, E. M. T. Dieleman, Y. Lievens, Dirk De Ruysscher, S. B. Schagen, M. B. de Ruiter, Jan C de Munck, Jose Belderbos

      • Resumen

      págs. 178-186

      

    • Bloodstream infection in patients with head and neck cancer: a major challenge in the cetuximab era

      María del Mar Marin Melia, Carlota Gudiol González, F. Castet, M. Oliva, Inmaculada Peiró Martínez, C. Royo Cebrecos, Jordi Carratalà Fernández, Ricard Mesía Nin

      • Resumen

      págs. 187-196

      

    • Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma

      L.-L. Deng, H.-B. Deng, C.-L. Lu, G. Gao, F. Wang, Yu Yang

      • Resumen

      págs. 197-205

      

    • The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study

      Theodoros Karantanos, S. Karanika, B. Seth, G. Gignac

      • Resumen

      págs. 206-212

      

    • The value of radical radiotherapy in the primary tumor of newly diagnosed oligo-metastatic nasopharyngeal carcinoma patients

      H. Shuang, J. Feng, C. Caineng, J. Qifeng, J. Tin, Chen Yuanyuan, C. Xiaozhong

      • Resumen

      págs. 213-219

      

    • iTRAQ-based proteomic analysis of DMH-induced colorectal cancer in mice reveals the expressions of β-catenin, decorin, septin-7, and S100A10 expression in 53 cases of human hereditary polyposis colorectal cancer

      G. Liu, F. Fei, J. Qu, X. Wang, Y. Zhao, Y. Li, Shiwu Zhang

      • Resumen

      págs. 220-231

      

    • Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification

      J. Wei, T. Yao, Y. Wang, L. Li, C. Pan, Nianqing Zhang

      • Resumen

      págs. 232-238

      

  • Brief Research Article

    • Outcomes of early-stage breast cancer patients treated with sequential anthracyclines–taxanes in relationship to relative dosing intensity: a secondary analysis of a randomized controlled trial

      Omar Mohammed Abdel-Rahman

      • Resumen

      págs. 239-245

      

  • Correspondence

    • Controversies in the management of stage I seminoma: adjuvant carboplatin revisited

      Jorge Aparicio Urtasun, Josefa Terrasa Pons

      págs. 246-247